In view of the latest development of the COVID-19 pandemic, our public service counters have been resumed. Consumers may call our hotline 2929 2222 to make appointments for enquiries, complaints and gift redemption at our Consumer Advice Centres. Alternatively, consumers may make use of our web forms via the following links for enquiries and complaints:
Batch recall of Largactil 50mg／2ml Solution for Injection
The Department of Health (DH) today (November 27) endorsed two licensed drug wholesalers, namely Sino-Asia Pharmaceutical Supplies Ltd (Sino-Asia) and Vantone Medical Supplies Co Ltd (Vantone), to recall one batch (batch number: A90142) of Largactil 50mg/2ml Solution for Injection from the market due to a potential quality issue.
The DH noticed from overseas drug regulatory agency that the manufacturer is recalling the affected batch due to an increased level of an impurity is found in the above batch of product. As a precautionary measure, the wholesalers voluntarily recall the affected batch of the product from the Hong Kong market.
The aforementioned product, containing chlorpromazine, is an antipsychotic prescription medicine. The product is not registered in Hong Kong but was imported for the treatment of particular patients by registered medical practitioners. According to the wholesalers, the affected batch has been supplied to the Hospital Authority and private hospitals.
The wholesalers have set up hotlines to answer related enquiries: Sino-Asia (2573 2552) and Vantone (2601 2877).
So far, the DH has not received any adverse reaction reports in connection with the affected product. The DH will closely monitor the recall.
Patients who require use of the above product should seek advice from their attending doctors if in doubt.